OncoGEMINI
OncoGEMINI enables identification and analysis of biologically and clinically relevant tumor variants from multi-sample and longitudinal tumor sequencing data.
Key Features:
- GEMINI-compatible database: Uses a GEMINI-compatible database generated from annotated Variant Call Format (VCF) files to leverage existing genomic annotations.
- Filtering capabilities: Provides filtering of tumor variants based on included genomic annotations and allele frequency signatures.
- Handling tumor heterogeneity: Facilitates identification and tracing of mutations within diverse subclonal populations across samples.
- Longitudinal analysis: Stores tumor sampling timepoints in a searchable database to observe changes in variant allele frequencies over time.
- External annotation integration: Integrates CIViC and DGIdb annotations to associate mutations with cancer interpretation and potential therapeutic targets.
Scientific Applications:
- Mutation prioritization: Prioritizes mutations likely contributing to tumor evolution using annotations and allele frequency dynamics.
- Therapeutic target identification: Identifies potential therapeutic targets within heterogeneous tumors by querying CIViC and DGIdb annotations.
- Longitudinal variant tracing: Traces trajectories of somatic and inherited variations across biopsies and timepoints to monitor clonal dynamics.
Methodology:
Generates a GEMINI-compatible database from annotated Variant Call Format (VCF) files; creates a searchable database including tumor sampling timepoints; applies filters based on genomic annotations and allele frequency signatures; and integrates CIViC and DGIdb annotations.
Topics
Details
- License:
- MIT
- Tool Type:
- command-line tool
- Programming Languages:
- Python, Shell
- Added:
- 1/18/2021
- Last Updated:
- 3/13/2021
Operations
Publications
Nicholas TJ, Cormier MJ, Huang X, Qiao Y, Marth GT, Quinlan AR. OncoGEMINI: Software for Investigating Tumor Variants From Multiple Biopsies With Integrated Cancer Annotations. Unknown Journal. 2020. doi:10.1101/2020.03.10.979591.